Antidepressant competition

Forest also disputes Warner-Lambert's assertion that the Federal Trade Commission would not necessarily require a divestment in the event of a merger because of overlaps between Celexa and either AHP's Effexor or Pfizer's Zoloft. "We cannot comment on any action the FTC might take, but even to suggest that those three products are not directly competitive would certainly surprise the marketing department at Parke-Davis as well as the physicians they and we have both been calling on for more than a year," Solomon wrote